Neuronetics STIM Clinical Services — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's clinical services — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Neuronetics's clinical services — gross profit?
- Neuronetics (STIM) reported clinical services — gross profit of $6.09M in Q1 2026.
- How has Neuronetics's clinical services — gross profit changed year-over-year?
- Neuronetics's clinical services — gross profit increased by 9.2% year-over-year, from $5.57M to $6.09M.
- What does clinical services — gross profit mean?
- This metric is calculated as the revenue from clinical services minus the direct costs of providing those services. It reflects the fundamental profitability of the clinical services business model before accounting for broader operating expenses.